Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma.
Altundag
Kadri
K
Elkiran
Emin Tamer
ET
Altundag
Ozden
O
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000503:physiopathology*; D002277:Carcinoma / Q000209:etiology* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D015203:Reproducibility of Results; D042461:Vascular Endothelial Growth Factor A / Q000032:analysis*
D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D042461:Vascular Endothelial Growth Factor A